The U.S. Food and Drug Administration cleared Optovue’s epithelial thickness mapping software for quantitative measurements of the epithelial and stromal layers of the cornea. The company says that epi-mapping is the first non-contact, quantitative method for making corneal epithelial and stromal measurements, and the only FDA-cleared product indicated to provide corneal epithelial and stromal measurements that aid in the diagnosis, documentation and management of ocular health and disease in adults.
Pre-surgical assessment with epi-mapping can help determine whether patients are suitable for refractive procedures, and the software provides information about how the eye is healing after refractive and corneal surgery, the company says.
For more information, visit optovue.com.
Easyret Photocoagulator Laser
In late July, Quantel Medical announced FDA approval of the Easyret 577nm yellow photocoagulator for the treatment of certain forms of macular edema and peripheral retinal pathologies.
Quantel highlights the Easyret’s broad range of settings for treatment of pathologies such as diabetic retinopathy, macular edema and central serous chorioretinopathy. With the new Easyret, surgeons can select MultiSpot mode for a pattern of simultaneous targets of treatment, and it also comes equipped with SubLiminal mode, enabling surgeons to customize a train of short pulses to manage the thermal impact on targeted tissues.
For more information on Quantel Medical’s Easyret, visit quantel-medical.com/products/52-easyret.